×
About 11,200 results

ALLMedicine™ Mitral Regurgitation Center

Research & Reviews  3,860 results

Machine Learning for Pediatric Echocardiographic Mitral Regurgitation Detection.
https://doi.org/10.1016/j.echo.2022.09.017
Journal of the American Society of Echocardiography : Off... Edwards LA, Feng F et. al.

Oct 4th, 2022 - Echocardiography-based screening for valvular disease in at-risk asymptomatic children can result in early diagnosis. These screening programs, however, are resource intensive, and may not be feasible in many resource-limited settings. Automated e...

Respect or resect in Barlow disease.
https://doi.org/10.1111/jocs.16993
Journal of Cardiac Surgery; Dreyfus GD, Dulguerov F

Oct 3rd, 2022 - Mitral regurgitation in Barlow disease may still be challenging to be repaired. Most often it involves the posterior leaflet. Many techniques and concepts are currently available; the main goal being to restore a good surface of coaptation. Basic ...

Robotic degenerative mitral repair: Factors associated with intraoperative revision and...
https://doi.org/10.1016/j.jtcvs.2022.06.027
The Journal of Thoracic and Cardiovascular Surgery; Chen Q, Roach A et. al.

Oct 2nd, 2022 - National registry data show wide variability in degenerative mitral repair rates and infrequent use of intraoperative repair revision to eliminate residual mitral regurgitation (MR). The consequence of uncorrected mild residual MR is also not clea...

Augmenting mitral valve repair evaluation with intraoperative left ventricle pressure m...
https://doi.org/10.1093/icvts/ivac242
Interactive Cardiovascular and Thoracic Surgery; Issa H, Deng M et. al.

Sep 30th, 2022 - Surgical mitral valve repair remains the gold standard treatment of mitral regurgitation due to degenerative disease. Surgery is performed on the quiescent heart; therefore, assessments of valve repair success can only be made following separation...

Midterm outcomes of mitral valve repair versus replacement in elderly patients: A prope...
https://doi.org/10.1111/jocs.16972
Journal of Cardiac Surgery; Muncan B, Amabile A et. al.

Sep 29th, 2022 - Current literature reports better short-term mortality rates in mitral valve repair over replacement in elderly patients. However, valve durability, postoperative complications, and reintervention rates in these cohorts remain understudied. As suc...

see more →

Guidelines  5 results

Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic ...
https://doi.org/10.1016/j.echo.2022.03.012
Journal of the American Society of Echocardiography : Off... Nagueh SF, Phelan D et. al.

Jun 7th, 2022 - Hypertrophic cardiomyopathy (HCM) is defined by the presence of left ventricular hypertrophy in the absence of other potentially causative cardiac, systemic, syndromic, or metabolic diseases. Symptoms can be related to a range of pathophysiologic ...

2020 Focused Update of the 2017 ACC Expert Consensus Decision Pathway on the Management...
https://doi.org/10.1016/j.jacc.2020.02.005
Journal of the American College of Cardiology; Bonow RO, O'Gara PT et. al.

Feb 19th, 2020 - Mitral regurgitation (MR) is a complex valve lesion that can pose significant management challenges. This expert consensus decision pathway emphasizes that recognition of MR should prompt an assessment of its etiology, mechanism, and severity, as ...

CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgita...
https://doi.org/10.1016/j.cjca.2019.11.036
The Canadian Journal of Cardiology; O'Meara E, McDonald M et. al.

Feb 10th, 2020 - In this update, we focus on selected topics of high clinical relevance for health care providers who treat patients with heart failure (HF), on the basis of clinical trials published after 2017. Our objective was to review the evidence, and provid...

Transcatheter therapies for mitral regurgitation: a professional society overview from ...
https://doi.org/10.1016/j.jtcvs.2013.12.002
The Journal of Thoracic and Cardiovascular Surgery; O'Gara PT, Calhoon JH et. al.

Feb 18th, 2014 - Transcatheter therapies for mitral regurgitation: a professional society overview from the American College of Cardiology, The American Association for Thoracic Surgery, Society for Cardiovascular Angiography and Interventions Foundation, and The ...

Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system.
https://doi.org/10.1007/s00392-013-0614-x
Clinical Research in Cardiology : Official Journal of The... Boekstegers P, Hausleiter J et. al.

Sep 12th, 2013 - The interventional treatment of mitral valve regurgitation by the MitraClip procedure has grown rapidly in Germany and Europe during the past years. The MitraClip procedure has the potential to treat high-risk patients with secondary mitral valve ...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  255 results

Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS
https://clinicaltrials.gov/ct2/show/NCT01626079

Sep 28th, 2022 - Prospective, randomized, parallel-controlled, multicenter clinical evaluation of the MitraClip device for the treatment of clinically significant functional mitral regurgitation in symptomatic heart failure subjects who are treated per standard of...

NHLBI DIR Transcatheter Mitral Cerclage Annuloplasty Early Feasibility Study
https://clinicaltrials.gov/ct2/show/NCT03929913

Sep 27th, 2022 - Functional mitral regurgitation (also known as secondary mitral regurgitation) is a common complication of left ventricular dysfunction. Ventricular dysfunction leads to dilation, which in turn leads to mitral annular dilation and leaflet traction...

Treatment of Mitral Regurgitation Using a Minimally Invasive Approach With the HARPOON Device.
https://clinicaltrials.gov/ct2/show/NCT04382612

Sep 26th, 2022 - This trial is a single arm, prospective, multi-center, non-randomized and open-label post-market study that will evaluate subjects for up to 5 years post treatment.

A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation
https://clinicaltrials.gov/ct2/show/NCT04147884

Sep 22nd, 2022 - The Millipede Feasibility Study is a prospective, open-label, single-arm study to assess the safety and feasibility/performance of the Millipede Transcatheter Annuloplasty Ring System in subjects with functional mitral regurgitation. The study wil...

see more →

News  357 results

Optimized HF Meds May Lessen MR Severity, Perhaps Avoiding MV Repair
https://www.medscape.com/viewarticle/981772

Oct 3rd, 2022 - Among the benefits of fully optimized medical therapy in heart failure with reduced ejection fraction (HFrEF) may be, indirectly, lessened severity of associated mitral regurgitation (MR) that might render invasive mitral valve (MV) repair unneces...

Fourth-gen transcatheter mitral valve shows clinical, procedural improvements
https://www.mdedge.com/cardiology/article/258016/interventional-cardiology-surgery/fourth-gen-transcatheter-mitral-valve
Ted Bosworth

Sep 19th, 2022 - The design improvements introduced in the fourth-generation device for transcatheter mitral valve repair, called the MitraClip G4 (Abbott), appears to yield better outcomes than previous iterations, according to a multinational postapproval study.

Fourth-Gen Transcatheter Mitral Valve Shows Clinical, Procedural Improvements
https://www.medscape.com/viewarticle/981020

Sep 19th, 2022 - The design improvements introduced in the fourth-generation device for transcatheter mitral valve repair, called the MitraClip G4 (Abbott), appears to yield better outcomes than previous iterations, according to a multinational postapproval study ...

In Cardiogenic Shock, Edge-to-Edge Mitral Valve Repair Improves Outcome
https://www.medscape.com/viewarticle/980977

Sep 17th, 2022 - In patients with severe mitral regurgitation (MR) and cardiogenic shock, successful transcatheter edge-to-edge repair (TEER) is associated with a substantial reduction in all-cause mortality and lower morbidity at 1 year, according to an analysis ...

PASCAL for MV Repair Noninferior to MitraClip in CLASP IID, FDA Took Notice
https://www.medscape.com/viewarticle/980979

Sep 17th, 2022 - A newly available transcatheter device for edge-to-edge mitral valve (MV) repair, named for a famed scientist-inventor, is similar to the long-available MitraClip (Abbott) for short-term efficacy and safety, suggests an interim but prespecified an...

see more →